Introduction 

COLUMVI (glofitamab-gxbm) is an innovative prescription medicine approved for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and large B-cell lymphoma (LBCL) who have already received two or more prior lines of therapy.

This treatment provides a new therapeutic option for patients with limited alternatives. The current approval of Columvi is conditional, based on response rates and durability of response in clinical studies. Ongoing research continues to evaluate its long-term effectiveness and safety.

It is important to note that the safety and effectiveness of Columvi in pediatric patients have not been established.

Glofitamab is a bispecific antibody, a modern class of drugs designed to target two different binding sites at once.

Columvi binds to T cells, a type of immune cell as well as B cells, including cancerous B cells bringing T cells and B cells close together. This enables T cells to release cytokines, which attack and kill malignant B cells. While this mechanism is effective against cancer cells, it may also reduce healthy B cells in the body.

Glofitamab (Columvi) represents a breakthrough in immuno-oncology, offering hope to patients with relapsed or refractory large B-cell lymphomas. Though not yet registered for sale in India, patients can still buy Glofitamab in India through authorized import programs with proper documentation.

The import of Glofitamab in India process requires a doctor’s prescription, diagnostic confirmation, and regulatory approvals. Through reliable licensed providers, patients can ensure safe and timely access to treatment. For families and caregivers seeking assistance, expert support is available to guide them on its latest availability India and the most updated pricing options.

Pricing: 

The Glofitamab price in India is not fixed since it is not yet registered for commercial distribution in India. The cost varies depending on the supplier’s country, shipping charges, and duration of treatment. Patients seeking to buy Glofitamab in India must go through authorized import channels.

Columvi is only available by prescription, and price quotes are provided after review of medical documents. Patients and caregivers can contact 247QualityMeds, an authorized import facilitator, for up-to-date pricing and guidance.

Steps to Import Columvi (glofitamab):

Since Columvi is not marketed in India through local pharmacies, it can be accessed via the Named Patient Import Program (NPIP).

Documents required to import Columvi (glofitamab) into India:

• A valid prescription from a qualified oncologist.
• Patient’s diagnostic test reports confirming DLBCL or LBCL.
• Government-issued patient ID proof.
• Import permit (if applicable).

Order confirmation process:

Orders are confirmed only after a valid prescription and required documents are submitted.

Following approval, Columvi is sourced from licensed international distributors and shipped securely to India.

This regulated process ensures patients can import Glofitamab India safely and legally.

Access Information: 

Glofitamab availability in  India is facilitated by licensed providers who import the medicine under patient-specific authorization. It is not sold at local chemists or retail pharmacies, but through approved channels, it can be delivered to major cities such as Delhi, Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Bangalore, Pune, Chandigarh, Jaipur, Lucknow, and others.

Key highlights of availability:

• Supplied only against a prescription.
• Sourced from genuine suppliers in the USA, Canada, Europe, or Australia.
• Ensures 100% transparency in cost and supply.
• Prescriptions are reviewed by registered pharmacists before dispatch.

Columvi can also be facilitated for patients worldwide, not just in India, provided all legal requirements are met. Patients with limited treatment options can benefit from advanced therapies like Columvi (Glofitamab). For clear guidance on Glofitamab availability and price in India, and to safely buy Columvi, patients and caregivers can rely on 24/7QualityMeds for trusted support.